4D MOLECULAR THERAPEUTICS IN

Ticker: FDMT CUSIP: 35104E100 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 117,719 Value ($000) $0 Avg Close $3.52 Range $2.23 - $5.10

Q4 2024

Shares 16,743 Value ($000) $0 Avg Close $7.85 Range $5.22 - $10.78

Q3 2024

Shares 37,662 Value ($000) $0 Avg Close $16.60 Range $10.56 - $28.93

Q2 2024

Shares 64,882 Value ($000) $1 Avg Close $25.09 Range $20.33 - $31.87

Q3 2022

Shares 23,997 Value ($000) $193 Avg Close $9.06 Range $6.70 - $11.95

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	117,719	$0	$3.52	$2.23 - $5.10
Q4 2024	16,743	$0	$7.85	$5.22 - $10.78
Q3 2024	37,662	$0	$16.60	$10.56 - $28.93
Q2 2024	64,882	$1	$25.09	$20.33 - $31.87
Q3 2022	23,997	$193	$9.06	$6.70 - $11.95